PARP inhibitors can be effective in broader group of patients

[News]

A pioneering class of drugs that target cancers with mutations in the BRCA breast cancer genes could also work against tumours with another type of genetic fault, a new study suggests.

More... (http://www.news-medical.net/news/20150320/PARP-inhibitors-can-be-effective-in-broader-group-of-patients.aspx)